Global Diabetes Diagnostics Markets, 2022 – Growing Prominence of Real-Time Glucose Sensing and Monitoring Drive Robust Demand

Dublin, Aug. 23, 2018 (GLOBE NEWSWIRE) -- The "Diabetes Diagnostics - Global Strategic Business Report" report has been added to's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Diabetes Diagnostics in US$ by the following Product Segments:

  • Continuous Glucose Monitoring (CGM) Systems
  • HbA1c Testing Devices
  • Blood Glucose Monitoring Devices

The report profiles 58 companies including many key and niche players such as:

  • A.Menarini Diagnostics Ltd. (UK)
  • Abbott Diabetes Care, Inc. (USA)
  • Acon Laboratories, Inc. (USA)
  • AgaMatrix, Inc. (USA)
  • Apex Biotechnology Corporation (Taiwan)
  • ARKRAY, Inc. (Japan)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • B. Braun Melsungen AG (Germany)
  • Becton, Dickinson and Company (USA)
  • BIONIME Corporation (Taiwan)
  • Bio-Rad Laboratories, Inc. (USA)
  • Danaher Corporation (USA)
  • Beckman Coulter, Inc. (USA)
  • HemoCue AB (Sweden)
  • DexCom, Inc. (USA)
  • Diazyme Laboratories Inc. (USA)
  • EKF Diagnostics Holdings Plc (UK)
  • LifeScan, Inc. (USA)
  • Medtronic PLC (Ireland)
  • Nova Biomedical Corporation (USA)
  • OSANG Healthcare Co., Ltd. (South Korea)
  • Roche Diabetes Care, Inc. (USA)
  • Sanofi S.A. (France)
  • Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
  • Siemens Healthineers (Germany)
  • Sinocare, Inc. (China)
  • PTS Diagnostics (USA)
  • Trividia Health, Inc. (USA)
  • TaiDoc Technology Corporation (Taiwan)
  • Tandem Diabetes Care, Inc. (USA)
  • Terumo Corporation (Japan)
  • Tosoh Bioscience, Inc. (USA)
  • Trinity Biotech plc (Ireland)
  • Ypsomed AG (Switzerland)

Key Topics Covered:

Study Reliability and Reporting Limitations
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Continuous Glucose Monitoring (CGM) Systems
HbA1c Testing Devices
Blood Glucose Monitoring Devices

Diabetes Diagnostics: Towards Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
Evolution of Diabetes Testing over the Years with Key Features in Each Period
Growth Drivers in a Nutshell
Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices
Diabetes Emerges as One of the Leading Causes of Death
Etiological Factors Causing Diabetes
Future Prospects Remain Favorable for Diabetes Diagnostics Market
Developed Regions Remain Primary Revenue Contributors
Developing Countries Continue to Offer Significant Growth Opportunities
Key Factors Driving Sales of Diabetes Diagnostics in Developing Regions
Steep Increase in Number of Hospitals & Diagnostics Centers
Growing Healthcare Awareness & Parallel Increase in Consumer Healthcare Spending
Stable Economic Scenario to Underpin Market Expansion

Growing Prominence of Real-Time Glucose Sensing and Monitoring Drive Robust Demand for Minimally-Invasive CGM Devices
CGM Market Gradually Breaks through Barriers to Adoption
Intensive Care Units: A Highly Promising Market for CGMs
Proven Efficacy for Development of Intervention Strategies Drives Demand for HbA1c Testing Devices
Rising Popularity of Near Patient Testing Benefits Prospects for HbA1c Devices
Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
Home HbA1c Testing: An Overview
Glycated Albumin: A Potential Threat to HbA1c?
Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap
Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?
HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
ESC and ADA Release Revised Guidelines for HbA1c Testing
Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Dominate Sales
Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring Systems
Self-Monitoring/Household Blood Glucose: Sustaining Growth in Demand
Key Trends in the Glucose Meter/Monitoring Systems
Smartphone Penetration Favors SMBG Market
Demand for BGM Products to Witness Varying Patterns in Developed and Developing Markets
Barriers to Adoption of New Technology in BGM Products
Accuracy Issues Plague Blood Glucose Meters Market
Advancements in Glucose Monitoring Devices Offers a New Ray of Hope
Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped Potential
Undiagnosed Diabetics: More Prone to Cardiovascular Diseases
Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
Heart Disease
High Blood Pressure
Kidney Disease
Nerve Disease
Dental Disease
Microvascular Complications (Small Blood Vessel Damage)
Diabetic Neuropathy
Macrovascular Complications (Large Blood Vessel Damage)
Cardiac Problems
Hypertension (High Blood Pressure)
Pregnancy Complications
Other Complications Resulting from Diabetes
Obsessive Compulsive Disorder
Foot Ulcers
Diabetic Ketoacidosis
Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular Complications
High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
Rising Expenditure on Diabetes Care Drives Diagnostic Devices Sales
Increasing Obesity Levels Underpins Market Growth

A Prelude
Continuous Glucose Monitoring (CGM) Systems
Hemoglobin A1c (HbA1c) Test
HbA1c Test Types
HbA1c Laboratory Testing
Analytical Techniques Used for Quantifying HbA1c in Labs
Standardization of HbA1c Results
HbA1c Point of Care Testing & Self-Monitoring
Blood Glucose Testing Devices
Blood Glucose Monitor/Meter
Diabetes Testing Supplies
Blood Glucose Test Strips
Lancet Device
Reagent Strips
Reagent Tablet
Diabetes: A Chronic Body Disorder
Diabetes Symptoms
Types of Diabetes
Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM)
Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (NIDDM)

Major Pharma Players Dominate Diabetes Diagnostics Market
Competition with Local Pharma Companies Intensifies in Regional Markets
Continuous Glucose Monitoring Systems (CGMS) Market
Medtronic Dominates the Global CGM Devices Market
Leading Companies Continue to Focus on CGM Innovations
Leading Companies and their CGM Innovations
Blood Glucose Monitoring (BGM) Devices Market
Quality Products at Low Prices: Mantra for Success in the Marketplace
After PDAs, SMBG Makers Turn to Mobile Devices to Woo Users on the Move
Competition in the HbA1c Testing Devices Market
Select Laboratory-based HbA1c Testing Products/Analyzers
Select Point of Care HbA1c Testing Products/Analyzers
Major POC HbA1c Tests in the Market
Select HbA1c POC Tests in the Market - A Comparison
Product Innovation is the Name of the Game for HbA1c Testing Device Companies
Manufacturers Focus on Offering Products for Developing Markets
Innovations & Product Advancements: Prime Focus Area for Vendors
mHealth Solutions for Diabetes Diagnosis
Non-invasive Wearable Glucose Testing Devices
Apple and Google to Develop Wearable Continuous Glucose Monitors
GlySens Focus on Developing Implantable Continuous Glucose Monitor
Researchers Develop Prototype of Wearable Closed-Loop System
Glucovation SugarSenz: Cloud Enabled CGM Device
EyeSense to Develop Affordable CGM Device
Insulin Pump with CGM Sensor
Glucose Monitoring through Smartphone Apps: The Latest Breakthrough
Bar-Illan University of Israel's Research for Non-invasive, Wearable Glucose Testing Device
Nanotechnology-based Breathalyzer for Non-Invasive Glucose Monitoring
EMG 1000: Needle-free Device for Glucose Monitoring
Glucase: Smartphone Case with Glucose Testing Kit
Painless Diabetes Monitoring Using NFC Technology
GlucoSense: Laser Device for Non-invasive Monitoring of Glucose Levels
ClearPath DS-120: Enabling Early Detection of Diabetes & Prediabetes
Sugar.IQ App: Powerful Features for Diabetics
NoStrip Technology: Eliminating Need for Individual Test Strips
Artificial Pancreas System (APS): The Future of Diabetes Care

5.1 Focus on Select Global Players

5.2 Product Launches/Approvals
Medtronic Receives CE Mark for MiniMed 670G Hybrid Closed Loop System
Medtronic and IBM Watson Health Launch Sugar.IQ Smart Diabetes Assistant
Nova Biomedical Bags USFDA Approval for StatStrip Glucose Hospital Meter in Critically Ill Patient Care
Medtronic Bags USFDA Approval for New Arm Indication for Guardian Sensor 3 CGM System
Tandem Diabetes Care Bags CE Mark Approval for t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration
DexCom Receives CE Mark for DexCom G6 System
DexCom Receives US FDA Marketing Approval for Dexcom G6 CGM System
Abbott Introduces Afinion 2 Analyser in the US
Roche Diabetes Care Launches Accu-Chek Instant S Glucometer in India
Senseonics Launches Remote Monitoring Feature for Eversense CGM Systems in EMEA
DarioHealth Launches Retail Sales of Dario BGM System on Amazon Prime
Senseonics Receives CE Mark Approval for Eversense XL CGM System
Abbott Bags US FDA Approval for FreeStyle Libre as a Replacement for BGM
ARKRAY Introduces New Aluminum Foil Packaged BG Sensor for PocketChem BG PG-7320
U.S. ARKRAY Launches ADAMS A1c HA-8180V System for Hemoglobin A1c Testing
ARKRAY Releases ADAMS A1c HA-8190V Glycohemoglobin Analyzer
Bionime Launches GM700SB Bluetooth Glucose Meter in Taiwan
Abbott Bags Health Canada License for FreeStyle Libre Flash Glucose Monitoring System
Medtronic Unveils MiniMed 670G Hybrid Closed Loop Insulin Delivery System
HemoCue Launches HemoCue HbA1c 501 System in Thailand
Roche Introduces Accu-Chek Guide System and SimplePay Savings Program
One Drop Launches iOS-compatible One Drop Chrome BGM Kit

5.3 Recent Industry Activity
PTS Diagnostics to Move World Headquarters to Whitestown from Indianapolis
Siemens Healthineers Inks Comarketing Agreement with Hill-Rom
Tandem Inks Distribution Deals in Australia and New Zealand
Senseonics Inks Development Agreement with Beta Bionics
DexCom Inks Distribution Deal with Terumo in Japan
Innovation Zed Teams Up with GlucoRx
Tandem Diabetes Care Inks Distribution Agreement with Movi SpA in Italy
Platinum Equity to Acquire LifeScan
Tandem Submits License Application to Health Canada for t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration
Tandem Diabetes Care Inks Distribution Deal with Rubin Medical
Ascensia Diabetes Care Expands Scope of Strategic Alliance with Insulet
Tandem Diabetes Care Commences Full-Scale Operations at Newly Launched San Diego Facility
Infopia Becomes OSANG Healthcare
DexCom Collaborates with Eli Lilly and Company
Animas to Discontinue Animas Vibe and OneTouch Ping Insulin Pumps Business
Abbott Acquires Alere
Fitbit Teams Up with Dexcom for Diabetes Care
Roche and Accenture to Develop Core Data Platform for Digital Diabetes Ecosystem
Radisens Raises Additional Funding to Commercialize its Diabetes Management Platform
Abbott Teams Up with Bigfoot Biomedical
Ascensia Diabetes Care Joins Hands with DexCom
Roche to Acquire mySugr
Roche Inks Exclusive Partnership Deal with Medtronic
Asensia Diabetes Care Inks Global Technology Partnership Deal with Glooko



7.1 The United States
A. Market Analysis
The United States: Largest Market for Diabetes Diagnostics
Diabetes: A Leading Cause of Death in the US & North America
Prevalence Varies by Race/Ethnicity
Aging Population: A Key Growth Factor
Economic Burden of Diabetes
Healthcare Reform Legislation: Impact on Diabetes Diagnostics
HbA1c Testing for Diabetes Detection Gains Support
ADA Recommends HbA1c Test for Diabetes Diagnosis
ADA Recommends New Guidelines for HbA1c Testing for Certain Patients
HbA1c - Increasingly Moving into Physician's Office
Growing Inclination towards CLIA-Waived Tests
Study Finds Dentist Visits to be an Opportunity for HbA1c-based Diabetes Screening & Management
Wearable and Non-Invasive Glucose Monitoring Devices Favored
FDA Guidance for Blood Glucose Meters
Emerging "Grey Market" for Testing Strips
Competitive Scenario
US Near Patient HbA1c Testing: A Highly Consolidated Market
CGM Devices: Highly Consolidated Marketplace
Companies Focus on Research for Better Diabetes Diagnostics
Drugstores Benefit from the Diabetic Care Category
Integrated Products: An Upcoming Trend
B. Market Analytics

7.4 Europe
A. Market Analysis
Diabetes Diagnostics Market in Europe - A Promising Outlook
Growing Uptake of HbA1c Tests Bodes Well
Proven Efficacy and Benefits of POCT HbA1C Tests Spur Adoption
Diabetes Statistics in Europe
Reimbursement Scenario
B. Market Analytics

7.4.1 France
A. Market Analysis
France: Diabetes & Aging Statistics
B. Market Analytics

7.4.2 Germany
A. Market Analysis
Germany: Diabetes & Aging Statistics
B. Market Analytics

7.4.3 Italy
A. Market Analysis
Italy: Diabetes & Aging Statistics
B. Market Analytics

7.4.4 The United Kingdom
A. Market Analysis
Self-Monitoring Blood Glucose Meters Gain Popularity
NHS England Launches Action for Diabetes Plan
NHS Guidelines for Lancets, Testing Strips, and Meters for Blood Glucose Testing
NICE Recommendations for Self-Monitoring Blood Glucose (SMBG)
Diabetes Statistics & Management - An Insight
Rising Obesity Cases - Increased Risk of Diabetes
Type 1 Diabetes in Children
B. Market Analytics

7.5 Asia-Pacific
A. Market Analysis
Asia-Pacific: A Market Laden with Opportunities
Rising Diabetes Incidence Offers Significant Growth Opportunities
Public and Private Sector Diabetes Care
Public Sector
Private Sector
Role of Healthcare Societies and Associations
Western Pacific Declaration on Diabetes
Technological Integration: An Emerging Trend in the Asia-Pacific Medical Devices Market
BGM Devices: Competitive Landscape
An Overview of Key Regional Markets
China: Lower Penetration Offers High Growth Potential
Reimbursement of Diabetes Diagnostics in China (2015): Glucose Meters and Test Strips' Reimbursement Status and Percentage
Increasing Diabetes Incidence Remains Growth Driver
Key Opportunity Indicator: Aging Population
Rising Diabetic Populace Spurs Growth in the Indian Market
Blood Glucose Monitoring Market: An Overview
Growth Stimulants & Challenges in a Nutshell
HbA1c Testing on Growth Spree
Most Glucose Meters in Indian Market Feature Imported Technology
ICMR Develops New Indigenous, Low-Cost Diabetes Detection Technology
Market Restraints
Rising Diabetes Cases - Opportunities for Diabetes Diagnostics
Key Opportunity Indicator: Aging Population
Australia: An Insight into Diabetes Statistics
Key Opportunity Indicator: Aging Population Statistics in Rest of Asia-Pacific
B. Market Analytics


  • Total Companies Profiled: 58 (including Divisions/Subsidiaries - 75)
  • The United States (35)
  • Canada (1)
  • Japan (4)
  • Europe (23)
    • France (2)
    • Germany (4)
    • The United Kingdom (8)
    • Italy (1)
    • Rest of Europe (8)
  • Asia-Pacific (Excluding Japan) (10)
  • Middle East (2)

For more information about this report visit

         Laura Wood, Senior Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Endocrinology 


You May Also Like

Immune Design to Present at Upcoming Investor Conferences in September

SEATTLE and SOUTH SAN FRANCISCO, Calif., Sept. 01, 2017 (GLOBE NEWSWIRE) -- Immune Design ...

ThromboGenics Business Update – Q3 2017

Press release                                                          20 October, 2017Regulated Information Diabetic Eye Disease programs progressing €53.7 million cash ...